ATE499610T1 - Verfahren zur diagnostik von tuberkulose - Google Patents

Verfahren zur diagnostik von tuberkulose

Info

Publication number
ATE499610T1
ATE499610T1 AT03738332T AT03738332T ATE499610T1 AT E499610 T1 ATE499610 T1 AT E499610T1 AT 03738332 T AT03738332 T AT 03738332T AT 03738332 T AT03738332 T AT 03738332T AT E499610 T1 ATE499610 T1 AT E499610T1
Authority
AT
Austria
Prior art keywords
agent
individual
tuberculosis
diagnostic
greater extent
Prior art date
Application number
AT03738332T
Other languages
English (en)
Inventor
Ajit Lalvani
Katie Ewer
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE499610T1 publication Critical patent/ATE499610T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Heating, Cooling, Or Curing Plastics Or The Like In General (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT03738332T 2002-07-05 2003-07-07 Verfahren zur diagnostik von tuberkulose ATE499610T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0215710.5A GB0215710D0 (en) 2002-07-05 2002-07-05 Diagnostic method
PCT/GB2003/002936 WO2004005925A2 (en) 2002-07-05 2003-07-07 Diagnostics method

Publications (1)

Publication Number Publication Date
ATE499610T1 true ATE499610T1 (de) 2011-03-15

Family

ID=9939991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03738332T ATE499610T1 (de) 2002-07-05 2003-07-07 Verfahren zur diagnostik von tuberkulose

Country Status (13)

Country Link
US (1) US7572597B2 (de)
EP (1) EP1520174B1 (de)
JP (1) JP4515257B2 (de)
AT (1) ATE499610T1 (de)
AU (1) AU2003244856B2 (de)
CA (1) CA2490172C (de)
CZ (1) CZ20053A3 (de)
DE (1) DE60336138D1 (de)
DK (1) DK1520174T3 (de)
GB (1) GB0215710D0 (de)
NZ (1) NZ537331A (de)
WO (1) WO2004005925A2 (de)
ZA (1) ZA200500056B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
DK1144447T3 (da) * 1998-11-04 2010-02-08 Isis Innovation Dianostisk tuberkulosetest
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
CA2556557A1 (en) * 2004-02-26 2005-09-09 Alk Abello A/S Method of evaluating the therapeutic potential of a vaccine for mucosal administration
EP2253956A3 (de) * 2004-05-24 2011-07-06 Baylor Research Institute Verfahren zur Beurteilung von Immunreaktionen
WO2006117538A2 (en) * 2005-04-29 2006-11-09 Fusion Antibodies Limited Assays for diagnosis of tuberculosis and uses thereof
GB0616238D0 (en) * 2006-08-15 2006-09-27 Inst Animal Health Ltd Diagnostic Test
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
JP2012503206A (ja) * 2008-09-22 2012-02-02 オレゴン ヘルス アンド サイエンス ユニバーシティ Ｍｙｃｏｂａｃｔｅｒｉｕｍｔｕｂｅｒｃｕｌｏｓｉｓ感染を検出するための方法
US8753292B2 (en) * 2010-10-01 2014-06-17 Angiodynamics, Inc. Method for locating a catheter tip using audio detection
IT1403092B1 (it) 2010-12-01 2013-10-04 Univ Degli Studi Modena E Reggio Emilia Metodo per la diagnosi e/o il monitoraggio della mucormicosi.
US9678071B2 (en) 2012-01-12 2017-06-13 Mayo Foundation For Medical Education And Research Detecting latent tuberculosis infections
US10401360B2 (en) 2013-04-29 2019-09-03 Mayo Foundation For Medical Education And Research Flow cytometry assay methods
US20140356930A1 (en) * 2013-06-03 2014-12-04 Panacea Pharmaceuticals Immune system enhancing immunotherapy for the treatment of cancer
CN107121546B (zh) * 2014-12-17 2019-03-22 中山大学 用于检测结核分枝杆菌感染的抗原刺激物、试剂盒及其应用
US10684275B2 (en) 2016-12-14 2020-06-16 Becton, Dickinson And Company Methods and compositions for obtaining a tuberculosis assessment in a subject
EP3976764B1 (de) * 2019-05-30 2025-07-23 Viti, Inc. Verfahren zum erkennen einer infektion mit dem mycobakterium tuberculosis
CN113980145B (zh) * 2021-11-08 2022-08-12 成都可恩生物科技有限公司 一种结核分枝杆菌融合蛋白及其制备方法和应用
CN117777259B (zh) * 2024-02-23 2024-06-07 上海科新生物技术股份有限公司 检测结核感染的抗原组合物、试剂盒及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640706B1 (fr) * 1988-12-20 1991-02-01 Roulements Soc Nouvelle Roulement a capteur d'informations
DK1144447T3 (da) * 1998-11-04 2010-02-08 Isis Innovation Dianostisk tuberkulosetest
JP5010079B2 (ja) * 1999-07-13 2012-08-29 スタテンズ セーラム インスティテュート マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法
NZ526807A (en) * 2001-01-08 2005-03-24 Isis Innovation Assay to determine efficacy of treatment for mycobacterial infection

Also Published As

Publication number Publication date
WO2004005925A2 (en) 2004-01-15
US20050208594A1 (en) 2005-09-22
US7572597B2 (en) 2009-08-11
JP2005532546A (ja) 2005-10-27
JP4515257B2 (ja) 2010-07-28
EP1520174A2 (de) 2005-04-06
CA2490172C (en) 2012-01-10
ZA200500056B (en) 2006-06-28
EP1520174B1 (de) 2011-02-23
AU2003244856B2 (en) 2010-09-16
CZ20053A3 (cs) 2005-05-18
CA2490172A1 (en) 2004-01-15
AU2003244856A1 (en) 2004-01-23
DK1520174T3 (da) 2011-06-14
GB0215710D0 (en) 2002-08-14
DE60336138D1 (de) 2011-04-07
WO2004005925A3 (en) 2004-03-18
NZ537331A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
ATE499610T1 (de) Verfahren zur diagnostik von tuberkulose
ES2523837T3 (es) Agentes de unión específica al factor de crecimiento de hepatocitos
WO2003028582A3 (en) Bovine pregnancy test
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
DK104590D0 (da) Hiv-peptider, kunstige hiv-antigener og immunoassay
DE69201441D1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
ATE172743T1 (de) Nachweis von kollagenabbau -i(in vivo)
EP2147928A3 (de) Auf Peptiden basierte Immunisierungstherapie zur Behandlung von Atherosklerose und Entwicklung von Peptid-basierten Assays zur Bestimmung von Immunreaktionen gegen oxidiertes Lipoprotein geringer Dichte
DK2230299T3 (da) Hidtil ukendt cytokin ZCYTOR17-ligand
CY1113124T1 (el) Μεθοδοι ανιχνευσης αλληλουχιων νουκλεϊκων οξεων σε ουρα
PT97159A (pt) Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
FR2816410B1 (fr) Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
NZ535908A (en) HIV regulatory and auxilliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
DE60230792D1 (de) Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm-erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
FR2828934B1 (fr) Test de l'immunite cellulaire par des peptides fixes sur support solide
DE60012723D1 (de) Verfahren zur bestimmung von disaccharidasen
DE60336214D1 (de) Methoden zur analyse von antikörperdisulfidisomere
DK1254374T3 (da) Fremgangsmåde til diagnose af effektiviteten ved xenotype-antistofbehandling
HUP0204426A2 (en) A computer based method for identifying conserved invariant peptide motifs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties